releases: https://www.sanders.senate.gov/newsroom/must-read/specialty-drugs-now-cost-more-than-the-median-household-income
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.sanders.senate.gov/newsroom/must-read/specialty-drugs-now-cost-more-than-the-median-household-income | Specialty drugs now cost more than the median household income | 2015-11-20 | 2015 | 2015-11 | Independent | House | VT | Bernard Sanders | S000033 | www.sanders.senate.gov | legacy | Specialty drugs now cost more than the median household income By: Carolyn Y. Johnson Friday, November 20, 2015 The average annual retail cost of specialty drugs used to treat complex diseases such as cancer, rheumatoid arthritis and multiple sclerosis now exceeds the median U.S. household income,according to a report to be published Friday. The study of 115 specialty drugs found that a year's worth of prescriptions for a single drug retailedat $53,384 per year, on average, in 2013 -- more than the median U.S. household income, double the median income of Medicare beneficiaries, and more than three times as much as the average Social Security benefit in the same year. The report was prepared by the AARP Public Policy Institute to highlightthe impact of drug priceson seniors. "We're talking about drugs that are now costing more than a lot of people are making in a year," said Leigh Purvis, director of health services research at the AARP Public Policy Institute. Continue reading here. | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |